登录新浪财经APP 搜索【信披】查看更多考评等级 9月15日，康泰医学通过全景网"投资者关系互动平台"以网络远程方式召开业绩说明会，众多投资者通 过网上提问参与此次活动。公司董事、总经理杨志山，副总经理、董事会秘书、财务总监郑敏接待并回 答了投资者提问，透露了公司在产品研发、市场布局等方面的重要信息。 投资者活动关键信息投资者活动关系类别：业绩说明会时间：2025年9月15日（周一）下午15:00 - 17:00 地点：通过全景网"投资者关系互动平台"（https://ir.p5w.net）网络远程召开参与单位名称：投资者网上 提问上市公司接待人员姓名：董事、总经理杨志山；副总经理、董事会秘书、财务总监郑敏 投资者关系活动主要内容具身运动康复智能装备成果转化：2025年4月，由河北工业大学牵头，康泰医 学与复旦大学、燕山大学合作的"具身运动康复智能装备关键技术与应用"项目获2024年度河北省科技进 步奖一等奖。项目中的生理电信号检测技术已用于公司心电、肌电等产品技术升级，推动科研成果向业 务转化。护城河产品开发：公司重点进行中高端、院线类及医疗器械蓝海产品的技术攻关与研发，对现 有心电、血氧等产品升级，同时推 ...

Group 1: Product Development and Innovation - The company has developed key technologies in "embodied motion rehabilitation intelligent equipment," which won the 2024 Hebei Provincial Science and Technology Progress Award [2] - Ongoing projects include medical endoscopes, in vitro diagnostic products, and dental consumables to meet changing market demands [3] - The company focuses on high-end products and has optimized existing products in ECG, blood pressure, and blood oxygen categories while actively developing new products [2] Group 2: Market Strategy and Expansion - The company is enhancing its domestic market presence through deep cooperation with leading e-commerce platforms to increase brand awareness [4] - Plans to expand into Southeast Asia, Africa, and South America are underway, targeting the growing demand for cost-effective medical devices in these regions [6] - The company aims to improve global market coverage and penetration through localized construction and cross-border e-commerce initiatives [6] Group 3: Financial Performance and Governance - The company's performance in the second quarter was not profitable, with profits primarily from the first quarter; management remains confident in future growth [7] - Shareholder reductions in holdings are attributed to personal financial needs and comply with legal regulations [7] - Recent changes in the supervisory board were part of normal governance optimization and did not involve any collective board incidents [4] Group 4: Technological Advancements - The company is actively investing in AI technology, focusing on integrating AI with medical devices and developing algorithms for patient monitoring [7] - Innovations include multi-mode temperature detection and pulse wave-based respiratory rate calculations, contributing to the advancement of smart healthcare [7]